TY - JOUR
T1 - National protocol for diagnosis and care of congenital aniridia
T2 - Summary for the attending physician
AU - Groupe Rédacteur Relecteur PNDS Aniridie
AU - Bremond-Gignac, D.
AU - Robert, M.
AU - Daruich, A.
AU - Borderie, V.
AU - Chiambaretta, F.
AU - Valleix, S.
AU - Borderie, Vincent
AU - Bourges, Jean Louis
AU - Calvas, Patrick
AU - Chiambaretta, Frédéric
AU - Copin, Henri
AU - Daien, Vincent
AU - Labbé, Antoine
AU - Le Bail, Béatrice
AU - Mortemousque, Bruno
AU - Robert, Matthieu
AU - Rozet, Jean Michel
AU - Sauer, Arnaud
AU - Valleix, Sophie
AU - Aberdam, Daniel
AU - Abitbol, Marc
AU - Aidan, Nathalie
AU - Audo, Isabelle
AU - Bahi-Buisson, Nadia
AU - Barbieri, Emmanuelle
AU - Basille, Fernand
AU - Bouet, Aurélie
AU - Bruere, Lénaïc
AU - Bursztyn, Joseph
AU - Cochener-Lamard, Béatrice
AU - Daruich-Matet, Alejandra
AU - Denis, Danièle
AU - Denis, Philippe
AU - De Vergnes, Nathalie
AU - El Maftouhi, Adil
AU - Forbeaux Glize, Audrey
AU - Gabison, Eric
AU - Grundeler, Jean Philippe
AU - Hoffart, Louis
AU - Igla, Sophie
AU - Jouanjan, Gaëlle
AU - Laumonier Demory, Elsa
AU - Leroy, Camille
AU - Le Meur, Guylène
AU - Mincheva, Zoia
AU - Plat, Elisabeth
AU - Rigal-Sastourne, Charlotte
AU - Romana, Serge
AU - Rousseau, Antoine
AU - Salomon, Rémi
N1 - Publisher Copyright:
© 2022 Elsevier Masson SAS
PY - 2022/6/1
Y1 - 2022/6/1
N2 - Congenital aniridia is a rare panocular disease defined by a national diagnostic and care protocol (PNDS) validated by the HAS. In most cases, it is due to an abnormality in the PAX6 gene, located at 11p13. Aniridia is a potentially blinding autosomal dominant disease with high penetrance. The prevalence varies from 1/40,000 births to 1/96,000 births. Approximately one third of cases are sporadic. Ocular involvement includes complete or partial absence of iris tissue, corneal opacification with neovascularization, glaucoma, cataract, foveal hypoplasia, optic disc hypoplasia and ptosis. These ocular disorders coexist to varying degrees and progress with age. Congenital aniridia manifests in the first months of life as nystagmus, visual impairment and photophobia. A syndromic form such as WAGR syndrome, WAGRO syndrome (due to the risk of renal Wilms tumor) or Gillespie syndrome (cerebellar ataxia) must be ruled out. Systemic associations may include diabetes, due to expression of the PAX6 gene in the pancreas, as well as other extraocular manifestations. Initial assessment is best carried out in a referral center specialized in rare ophthalmologic diseases, with annual follow-up. The management of progressive ocular involvement must be both proactive and responsive, with medical and surgical management. Visual impairment and photophobia result in disability, leading to difficulties in mobility, movement, communication, learning, fine motor skills, and autonomy, with consequences in personal, school, professional, socio-cultural and athletic life. Medico-socio-educational care involves a multidisciplinary team. Disability rehabilitation must be implemented to prevent and limit situations of handicap in activities of daily living, relying on the Commission for the Rights and Autonomy of People with Disabilities (CDAPH) within the Departmental House of People with Disabilities (MDPH). The general practitioner coordinates multidisciplinary medical and paramedical care.
AB - Congenital aniridia is a rare panocular disease defined by a national diagnostic and care protocol (PNDS) validated by the HAS. In most cases, it is due to an abnormality in the PAX6 gene, located at 11p13. Aniridia is a potentially blinding autosomal dominant disease with high penetrance. The prevalence varies from 1/40,000 births to 1/96,000 births. Approximately one third of cases are sporadic. Ocular involvement includes complete or partial absence of iris tissue, corneal opacification with neovascularization, glaucoma, cataract, foveal hypoplasia, optic disc hypoplasia and ptosis. These ocular disorders coexist to varying degrees and progress with age. Congenital aniridia manifests in the first months of life as nystagmus, visual impairment and photophobia. A syndromic form such as WAGR syndrome, WAGRO syndrome (due to the risk of renal Wilms tumor) or Gillespie syndrome (cerebellar ataxia) must be ruled out. Systemic associations may include diabetes, due to expression of the PAX6 gene in the pancreas, as well as other extraocular manifestations. Initial assessment is best carried out in a referral center specialized in rare ophthalmologic diseases, with annual follow-up. The management of progressive ocular involvement must be both proactive and responsive, with medical and surgical management. Visual impairment and photophobia result in disability, leading to difficulties in mobility, movement, communication, learning, fine motor skills, and autonomy, with consequences in personal, school, professional, socio-cultural and athletic life. Medico-socio-educational care involves a multidisciplinary team. Disability rehabilitation must be implemented to prevent and limit situations of handicap in activities of daily living, relying on the Commission for the Rights and Autonomy of People with Disabilities (CDAPH) within the Departmental House of People with Disabilities (MDPH). The general practitioner coordinates multidisciplinary medical and paramedical care.
KW - Cataract
KW - Congenital aniridia
KW - Foveal hypoplasia
KW - Gillespie syndrome
KW - Glaucoma
KW - PAX6 gene
KW - Visual impairment
KW - WAGR syndrome
U2 - 10.1016/j.jfo.2022.01.005
DO - 10.1016/j.jfo.2022.01.005
M3 - Review article
C2 - 35667788
AN - SCOPUS:85131347242
SN - 0181-5512
VL - 45
SP - 647
EP - 652
JO - Journal Francais d'Ophtalmologie
JF - Journal Francais d'Ophtalmologie
IS - 6
ER -